The Pinnacle of Weight Loss Innovation. Unmatched Value for Researchers.

🔬 Product Overview

Retatrutide represents a monumental leap in metabolic science Developed by Eli Lilly, this triple-hormone receptor agonist simultaneously targets GLP-1, GIP, and glucagon receptors, orchestrating a harmonious effect on appetite regulation, fat metabolism, and energy expenditure. This multifaceted approach positions Retatrutide as a formidable tool in metabolic health research. The 30mg vial offers the most cost-effective option for comprehensive and long-term research protocols, providing researchers with an economical solution without compromising on potency.

🚀 Key Benefits

• *Triple-Hormone Synergy: Engages three critical pathways—GLP-1, GIP, and glucagon receptors—to synergistically enhance weight loss and metabolic regulation.
• *Exceptional Weight Reduction: Clinical trials have demonstrated up to 24.2% body weight loss over 48 weeks with 12 mg dosing, surpassing results from other treatments like Ozempic and Mounjaro.
• *Enhanced Metabolic Health: Significant improvements in liver fat content and cardiometabolic markers have been observed, indicating broader health benefits.
• *Maximum Cost Efficiency: Purchasing the 30mg vial offers the lowest cost per milligram, making it the most economical choice for extensive research applications.

🧪 Composition

• *Active Ingredient: Retatrutide
• *Concentration: 30mg per vial
• *Form: Lyophilized peptide powder

📦 Usage & Storage

• Intended Us: For research purposes only.
• Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.

🛒 Order your 30mg Retatrutide today for £450.00